title: Managing overweight and obesity in adults to reduce cardiovascular disease risk.
abstract: Obesity is a leading preventable cause of death and disability worldwide. Obesity increases the risk for clinically identifiable risk factors for cardiovascular disease (CVD) as well as a host of other metabolic, sleep, and orthopedic disorders. Coordinated and systematic interventions are needed to manage obesity and reduce these risks. The Obesity 2 Expert Panel updated the previous guidelines and produced the "Guideline for the Management of Overweight and Obesity in Adults." The Panel used data from publications from years 1999 to 2011 to address five critical questions, provide evidence statements, and recommend creation of a treatment algorithm to guide decision making about clinical care. The current review discusses the evidence statements pertaining to CVD risk in the assessment and management of patients who are overweight and obese. We summarize the FDA-approved medications for the treatment of overweight and obesity and their impact on CVD risk and risk factors, as well as ongoing clinical trials which will further inform clinical practice.
authors.affiliation: Division of Primary Care Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, ebbert.jon@mayo.edu.
authors.forename: Jon O
authors.initials: JO
authors.lastname: Ebbert
authors.forename: Muhamad Y
authors.initials: MY
authors.lastname: Elrashidi
authors.forename: Michael D
authors.initials: MD
authors.lastname: Jensen
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D019468:Disease Management; D014943:Global Health; D006801:Humans; D009017:Morbidity / Q000639:trends; D009765:Obesity / Q000150:complications / Q000628:therapy*; D050177:Overweight / Q000150:complications / Q000628:therapy*; D012307:Risk Factors
references.citation: N Engl J Med. 1998 Sep 10;339(11):725-32
references.pmid: 9731088
references.citation: Lancet. 2011 Apr 16;377(9774):1341-52
references.pmid: 21481449
references.citation: J Pharmacol Exp Ther. 2008 May;325(2):577-87
references.pmid: 18252809
references.citation: J Clin Endocrinol Metab. 2011 Oct;96(10):3067-77
references.pmid: 21795446
references.citation: N Engl J Med. 2005 Mar 17;352(11):1138-45
references.pmid: 15784668
references.citation: J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023
references.pmid: 24239920
references.citation: Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16
references.pmid: 23800750
references.citation: N Engl J Med. 2010 Jul 15;363(3):245-56
references.pmid: 20647200
references.citation: Gastroenterol Clin North Am. 2010 Mar;39(1):69-79
references.pmid: 20202580
references.citation: Obes Res. 2003 Apr;11(4):556-62
references.pmid: 12690085
references.citation: N Engl J Med. 2007 Jan 18;356(3):213-5
references.pmid: 17229948
references.citation: JAMA. 2014 Jan 1;311(1):23-4
references.pmid: 24381963
references.citation: Am J Clin Nutr. 2012 Feb;95(2):297-308
references.pmid: 22158731
references.citation: JAMA. 2013 Jun 5;309(21):2240-9
references.pmid: 23736733
references.citation: Obesity (Silver Spring). 2012 Feb;20(2):330-42
references.pmid: 22051941
references.citation: Arch Intern Med. 2010 Sep 27;170(17):1566-75
references.pmid: 20876408
references.citation: Obesity (Silver Spring). 2012 Jul;20(7):1426-36
references.pmid: 22421927
references.citation: Ann Intern Med. 2005 Apr 5;142(7):532-46
references.pmid: 15809465
references.citation: Endocrinology. 2008 Mar;149(3):1323-8
references.pmid: 18039773
references.citation: Nutrition. 2000 Oct;16(10):961-6
references.pmid: 11054602
references.citation: Nutrition. 2000 Oct;16(10):967-75
references.pmid: 11054603
references.citation: N Engl J Med. 2012 Apr 26;366(17):1567-76
references.pmid: 22449319